Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20130525013456N7
IRCT20130525013456N7RecruitingPhase 3

Investigating the effect of Quetiapine on delirium in patients undergoing coronary artery bypass graft surgery; a double-blind clinical trial

Rasht University of Medical Sciences0 sites82 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
82
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 85 years (—)
Sex
All

Inclusion Criteria

  • •Elective patients who are candidates for coronary artery bypass surgery
  • •85- 35 years
  • •American Society of Anesthesiologists (ASA) III,IV
  • •GCS above 15 to be fully alert and able to communicate

Exclusion Criteria

  • •Liver and kidney failure
  • •Emergency surgery
  • •Confirmation of delirium before ICU admission
  • •Patients with a history of mental illness and cognitive behavioral problems before surgery
  • •Allergy to quetiapine and its ingredients

Investigators

Sponsor
Rasht University of Medical Sciences

Similar Trials

Completed
Not Applicable
Efficacy of quetiapine for delirium prevention in the hospitalized elderly medical patientsDeliriumQuetiapineDelirirumPreventionHospitalizedInternal medicineElderly
TCTR20190927001Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand122
Completed
Phase 3
Effect of Quetiapine in Preventing Delirium in ICU Patientspatient admitted to the intensive care unit.Delirium due to known physiological condition
IRCT20180520039739N5Esfahan University of Medical Sciences98
Recruiting
Not Applicable
Quetiapine as Prophylaxis for Delirium in CABGDelirium
NCT05801289Ain Shams University60
Unknown
Phase 3
Prophylactic Quetiapine on Delirium Prevention in Critically Ill PatientsDelirium
NCT02297763Seoul National University Hospital194
Active, not recruiting
Not Applicable
Effect of quetiapine XR on sleep in patients with major depression, as compared with mirtazapineDuring the past years, growing evidence of a pronounced antidepressant effect of quetiapine has been demonstrated in several studiesin the same time, quetiapine turned out to have sleep-promoting properties. Since in major depression, initial sleep complaints are among the most prominent symptoms, quetiapine appears as a drug which possibly can act simultaneously on depressive symptomatology and sleep complaints.MedDRA version: 9.1Level: LLTClassification code 10012399Term: Depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOS
EUCTR2008-003331-20-DETechnical University Munich, Klinikum rechts der Isar